Dr Li, Xue 李雪
- Health economics: budget impact and cost-effectiveness analyses
- Real-world outcomes research: burden of disease, health resource utilization and medication safety
- Patient-centered outcome research: barrier, preferenes and willingness-to-pay for novel treatments
- Health policy: the use of Big Data in health policy evaluation
Dr Shirley Li joined the Department of Pharmacology and Pharmacy since 2014 and appointed as Research Assistant Professor jointly by the Department of Pharmacology and Pharmacy, Department of Paediatrics and Adolescent Medicine and Department of Social Work and Social Administration since 2019. Before joining HKU, She obtained Master of Medicine at Peking Union Medical Colleage, Tsinghua University in 2009 and PhD in Public Health at the Chinese University of Hong Kong in 2013.
Dr Li is specialized in health economics and real-world outcome research (HEOR) with particular interests on health technology assessment (HTA) for new drugs market access, health policy evaluation using big data and patient-reported outcome research for willingness-to-pay assessment.
Dr Li has been highly involved in multiple health economics projects at Centre for Safe Medication and Practice Research at HKU, which had dynamic interactions with the government, industries, community, patients and other stakeholders. She has been published actively in the field of public health science and health policy, covering the therapeutic areas of infectious diseases and vaccinology, cardiovascular diseases, diabetes mellitus, autoimmune diseases and rare genetic disorders. She also serves as peer-reviewers for Value in Health, PlosOne and ISPOR conferences.
|Term Period||Position||Professional Societies|
|06/2019-present||Member||International Health Technology Assessment (HTAi)|
|07/2019-present||Vice-President (External)||ISPOR Hong Kong Chapter|
|06/2014-present||Member||The International Society for Pharmacoeconomics and Outcomes Research (ISPOR)|
|01/2017-present||Member||Asia Consortia- International Society for Pharmacoeconomics and Outcomes Research (ISPOR)|
|09/2017-present||Member||International Health Economic Association (iHEA)|
Are You Missing Publications, Invited Lectures? Click Me.